Announcements
ANNOUNCEMENTS
26 August 2022:
International ISEAPT Survey on Availability and Usage of EPA
The survey concluded on 30 July. Thanks to everyone for your participation. Data analysis is currently being carried out and results will be presented at the upcoming ISEAPT Summit during Dr. Yuichi Abe's keynote lecture on "EPA Practice: Past, Present and Future Trends". For more information on the summit, click here.
PAST ANNOUNCEMENTS
4 July 2022:
International ISEAPT Survey on Availability and Usage of EPA (dateline extended to 30 July)
There are currently about 839 responses to the survey as follows:
1. Argentina 20
2. Cambodia 27
3. Costa Rica 91
4. Hong Kong 0
5. Indonesia 100
6. Israel 43
7. Japan 113
8. South Korea 0
9. Kuwait 27
10. Lithuania 0
11. Malaysia 57
12. Singapore 43
13. Spain 53
14. Taiwan 3
15. United Kingdom 13
16. United States of America 9
17. Others 240
The dateline has been extended to July 30th. To participate, please click on the link below:
20 May 2022:
Inaugural ISEAPT Summit (23 to 25 September 2022)
The ISEAPT Board is pleased to announce that the inaugural ISEAPT Summit will be held in conjunction with the Indonesian Physiotherapy Association (IPA) annual congress, and hosted by IPA as follows:
Venue: Jakarta (in-person) and Zoom (online)
Date: 23 to 24 September (ISEAPT Summit); 23 to 25 September (IPA Congress)
Theme: Past, Present and Future of EPA
Registration: ISEAPT Summit (Free), send email to: iseapt2011@yahoo.com
IPA Congress https://fisioevent.com/pendaftaran/
For more information, click here.
20 May 2022:
International ISEAPT Survey on Availability and Usage of EPA (25 May to 25 July)
At the 8th Board Meeting on 23 September 2021, the ISEAPT Board tasked Yuichi Abe (Board Member) to prepare and conduct an online survey for all member countries on the availability and usage of EPA, and to present the results at the inaugural ISEAPT Summit. The English language survey was also translated into 5 other languages (Arabic, Hebrew, Indonesian, Japanese, Spanish). The results will serve as a baseline status of EPA and 5-year follow-up studies were also planned in order to monitor changes in usage trends. These studies will provide the ISEAPT Board members with data to guide decision making and strategies for implementation. To participate, please click on the link below:
Towards a new definition of Electrophysical Agents (proposed)
EPA is defined as the use of electrophysical and biophysical energies for the purposes of evaluation, treatment and prevention of impairments, activity limitations, and participation restrictions.
Evaluation procedures involving EPA include (but are not limited to) ultrasound imaging and electro-neurophysiological testing in order to assist with physical therapy diagnosis, guide treatment procedures and to evaluate treatment outcomes.
Treatment procedures involving EPA include (but are not limited to) the use of electromagnetic, acoustic and mechanical energies to produce biophysical effects at the cellular, tissue, organic and whole body levels in order to achieve physiological and clinical effects which serves to maintain and optimize health.
Treatment procedures involving EPA include (but are not limited to) the use of electromagnetic, acoustic and mechanical energies to produce biophysical effects at the cellular, tissue, organic and whole body levels in order to achieve physiological and clinical effects which serves to maintain and optimize health.